· 自动抓取 · 最新研究 · 1 分钟阅读
Advances in Digital Pathology and Artificial Intelligence in the Diagnosis of Myeloid Neoplasms.
Recent advances in digital pathology and artificial intelligence (AI) are transforming our ability to diagnose myeloid neoplasms, including acute myeloid leukemia (AML), myelodysplastic syndromes (MDS
Recent advances in digital pathology and artificial intelligence (AI) are transforming our ability to diagnose myeloid neoplasms, including acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN). Modern AI systems now achieve expert-level performance across peripheral blood smear assessment, bone marrow aspirate and biopsy interpretation, flow cytometry, cytogenetics, and next-generation sequencing; with many platforms surpassing 90% accuracy and en
本文自动抓取自 PubMed，原文链接：Advances in Digital Pathology and Artificial Intelligence in the Diagnosis of Myeloid Neoplasms.
原文发布日期：2026-05-28
